Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery

OBJECTIVE: Stereotactic radiosurgery (SRS) is routinely used to treat brain metastases from melanoma due to their radioresistant nature. The median survival for these patients is 4–6 months, according to earlier studies. The aim of this study was to evaluate prognostic factors that influence surviva...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Neurosurg
Главные авторы: Bian, Shelly X., Routman, David, Liu, Jonathan, Yang, Dongyun, Groshen, Susan, Zada, Gabriel, Trakul, Nicholas, Wong, Michael K., Yu, Cheng, Chang, Eric L.
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7469983/
https://ncbi.nlm.nih.gov/pubmed/27903181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2016.8.GKS161359
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы